SlideShare a Scribd company logo
Overview of the DoD
Ovarian Cancer
Research Program
Karen Wylie, Ph.D.
DoD OCRP Science Officer
The Geneva Foundation,
In support of the
Congressionally Directed Medical Research Programs
The views expressed in this presentation are those of the author and may
not reflect the official policy or position of the Department of the Army,
Department of Defense, or the U.S. Government.
2
Outline
 Overview of DoD OCRP & CDMRP
 DoD OCRP consumers
 Impact of the DoD OCRP
 Consortium Award
 Outcomes Consortium Award
 Ovarian Cancer Academy
3
History of the CDMRP and DoD OCRP
Congressionally Directed Medical Research Programs (CDMRP)
Organization which funds biomedical research globally
Unique partnership: U.S. Congress, Public & U.S. Military
 1992 grassroots campaign to increase Breast Cancer research funding
 Congress responded, DoD directed to manage $210 M
 CDMRP established, Breast Cancer Research Program 1st program
In 1997, the Ovarian Cancer Research Program (OCRP) was
added to CDMRP with an initial appropriation of $7.5 M.
FY1992 – FY2015 CDMRP has
 Grown to include 27 research programs
 Cancer, neurologic, orthopedic and military relevant areas
 Managed ~$9.7 Billion in appropriations
4
How does the OCRP fit into the DoD?
ARMY
MEDICAL COMMAND
(MEDCOM)
DEPARTMENT
OF DEFENSE
DEPARTMENT
OF THE ARMY
MEDICAL
RESEARCH
AND
MATERIEL
COMMAND
(USAMRMC)
CONGRESSIONALLY
DIRECTED MEDICAL
RESEARCH PROGRAMS
OCRP
OVARIAN
CANCER
RESEARCH
PROGRAM
5
DoD OCRP Vision and Mission
Vision: Eliminate ovarian cancer.
Mission: To support patient-centered
research to prevent, detect, treat &
cure ovarian cancer.
FY1997–FY2015 DoD OCRP
managed appropriations of $256.5 M
DoD OCRP addresses critical issues for
the OC patient & research communities
through different funding opportunities.
6
Outline
 Overview of DoD OCRP & CDMRP
 DoD OCRP consumers
 Impact of the DoD OCRP
 Consortium Award
 Outcomes Consortium Award
 Ovarian Cancer Academy
7
DoD OCRP Consumers: Role and Numbers
Who is an OCRP consumer?
An OCRP consumer is a patient
or a survivor living with ovarian cancer.
OCRP Consumer contributions
 Peer Review: 94, who provided
reviews for 225 panel assignments
 Programmatic Review:
9 Standing reviewers
10 Ad-hoc reviewers
8
Unique Partnerships
Demonstrate
need
Participate at
all levels
Passion and
perspective
Innovation
and gaps
Risk/Benefit
Product-
oriented
Add funds to
budget
Targeted
guidance
Program
management
Contracting
actions
Regulatory
requirements
IMPROVE
HEALTH
OUTCOME
9
DoD OCRP Funding
0
5
10
15
20
25
FY97 FY98 FY99 FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16
Millions($)
Fiscal Year
Congressional Appropriations for DoD OCRP
FY97-FY16
10
Outline
 Overview of DoD OCRP & CDMRP
 OCRP consumers
 Impact of the DoD OCRP
 Consortium Award
 Outcomes Consortium Award
 Ovarian Cancer Academy
11
Impact of the DoD OCRP
Unmet Needs / Long-Term Research Priorities
 Understand initiation and progression of OC
 Develop / improve diagnosis and treatment
 Increase prevention, improve QOL for survivors
 Investigate tumor response / resistance to treatment
 Develop and validate research tools to study OC
 Recruit / retain exceptional OC researchers
12
DoD OCRP Consortium Award
Focus … Prevention
Intent
To support a major multi-institutional research effort
 Focus on identifying and characterizing early changes in OC
 Innovative studies to reduce burden of OC through prevention.
FY10 Consortium Award: Dr. Kurman’s group / JHU
“Prevention of Ovarian High-Grade Serous Carcinoma
by Elucidating Its Early Changes”
 4 preclinical & 1 epidemiology project; JHU, MSKCC, Yale & UHN Toronto
 Hypothesis: Precursor of many HGSCs begins in the fallopian tube
 Results: Evaluated STICS as precursor lesions of HGSCs
Identifying molecular changes that precede the development of STICs
 Website: http://www.ovariancancerprevention.org/
13
Outcomes Consortium Award
Focus … Increase Survivorship
Intent
 Identify & understand predictors of disease outcomes
 Shift balance: Short-Term Survivors to Long-Term Survivors
 FY15 Outcomes Consortium Award
 Impact: accelerate predictors of disease outcomes into patient care.
 Consumer advocates involved in significant aspects of the proposed
project such as design, recruitment, and evaluation
 Two 4-year awards made by September 2016
14
Outcomes Consortium Award
Focus … Increase Survivorship
 Dr. Birrer’s group (Massachusetts General Hospital)
 “The Genomic, Epigenomic, & Quality-of-Life Characteristics of
Long-Term Survivors of OC”
 Characterize genomic, biologic, and biobehavioral basis for
long-term survivors of epithelial OC
 Dr. Pike’s group (Memorial Sloan Kettering Cancer Ctr.)
 “Multidisciplinary Ovarian Cancer Outcomes Group (MOCOG)”
 Investigate genetic, genomic, immune, & epidemiological
factors that may contribute, singly or in combination, to long-
term survival
Ovarian Cancer Academy: The Need
“Reducing the burden of
ovarian cancer requires
recruiting and, more
importantly, mentoring a
group of scientists and
clinicians who are
committed to building
sustained and productive
careers in ovarian cancer
research.”
Dr. Michael Seiden,
Integration Panel Chair, FY09
Building a Critical Mass of Dedicated OC Researchers
16
Ovarian Cancer Academy: Challenges
Challenges in Producing Dedicated OCRP Researchers
 Limited number of medical or research centers with
critical mass of mentors dedicated to OC research
 Funding an institutional training grant at a single
institution is expensive and often ineffective
 Too few junior scientists and physicians heading into
OC as a research career choice
 Peer groups for junior faculty interested in OC often
limited within their institutions
17
Ovarian Cancer Academy: Breaking Barriers
Focus…Seeding Next Generation of Dedicated OC Researchers
 Interactive Academy in a Virtual Environment
 Consists of:
 Academy Dean and Assistant Dean
 ~14 Early-Career Investigator (ECI)-Designated Mentor pairs from
different institutions
 Provides
 Mentoring
 Networking
 Peer group
 Collaborative opportunities
18
Ovarian Cancer Academy (OCA)
OCA: Early-Career Investigators, their Mentors and Leadership
19
Search Awards Site
http://cdmrp.army.mil
Research Highlights/News »
19
Search Awards & PublicationsResearch Programs
2020
Thank you…
For Your Unwavering Support

More Related Content

What's hot

Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016
Warren Kibbe
 
Converged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data SharingConverged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data Sharing
Warren Kibbe
 
Big data sharing
Big data sharingBig data sharing
Big data sharing
Warren Kibbe
 
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
Yasser Sami Abdel Dayem Amer
 
Frontiers of Predictive Oncology and Computing
Frontiers of Predictive Oncology and ComputingFrontiers of Predictive Oncology and Computing
Frontiers of Predictive Oncology and Computing
Warren Kibbe
 
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Leonard Davis Institute of Health Economics
 
Health economic modelling in bowel cancer
Health economic modelling in bowel cancerHealth economic modelling in bowel cancer
Health economic modelling in bowel cancer
ScHARR HEDS
 
resume 2014
resume 2014resume 2014
resume 2014
Laura Crocitto
 
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
Yasser Sami Abdel Dayem Amer
 
Lessons learned in scaling up
Lessons learned in scaling upLessons learned in scaling up
Lessons learned in scaling up
Warren Kibbe
 
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Cancer Institute NSW
 
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-ProgramsRCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
Brissan Guardado
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
cheweb1
 
176482 633754879714110000
176482 633754879714110000176482 633754879714110000
176482 633754879714110000
guestabde8b
 
Implementation science tailored to precision prevention
Implementation science tailored to precision preventionImplementation science tailored to precision prevention
Implementation science tailored to precision prevention
Graham Colditz
 
The Cochrane Collaboration
The Cochrane CollaborationThe Cochrane Collaboration
The Cochrane Collaboration
Cochrane.Collaboration
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Office of Health Economics
 
Oncoset symposium kibbe 201704
Oncoset symposium kibbe 201704Oncoset symposium kibbe 201704
Oncoset symposium kibbe 201704
Warren Kibbe
 
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceHow Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
SC CTSI at USC and CHLA
 
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
John Blue
 

What's hot (20)

Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016Nci clinical genomics data sharing ncra sept 2016
Nci clinical genomics data sharing ncra sept 2016
 
Converged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data SharingConverged IT Summit - NCI Data Sharing
Converged IT Summit - NCI Data Sharing
 
Big data sharing
Big data sharingBig data sharing
Big data sharing
 
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
Clinical Practice Guidelines for Hematology-Oncology in King Saud University ...
 
Frontiers of Predictive Oncology and Computing
Frontiers of Predictive Oncology and ComputingFrontiers of Predictive Oncology and Computing
Frontiers of Predictive Oncology and Computing
 
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
 
Health economic modelling in bowel cancer
Health economic modelling in bowel cancerHealth economic modelling in bowel cancer
Health economic modelling in bowel cancer
 
resume 2014
resume 2014resume 2014
resume 2014
 
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
Evidence-Based Clinical Practice Guidelines for Physical and Rehabiliatation ...
 
Lessons learned in scaling up
Lessons learned in scaling upLessons learned in scaling up
Lessons learned in scaling up
 
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
 
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-ProgramsRCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
 
Health economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development processHealth economic modelling in the diagnostics development process
Health economic modelling in the diagnostics development process
 
176482 633754879714110000
176482 633754879714110000176482 633754879714110000
176482 633754879714110000
 
Implementation science tailored to precision prevention
Implementation science tailored to precision preventionImplementation science tailored to precision prevention
Implementation science tailored to precision prevention
 
The Cochrane Collaboration
The Cochrane CollaborationThe Cochrane Collaboration
The Cochrane Collaboration
 
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
Do EQ-5D-3L and EQ-5D-5L Capture the Same Changes in Quality of Life Over Tim...
 
Oncoset symposium kibbe 201704
Oncoset symposium kibbe 201704Oncoset symposium kibbe 201704
Oncoset symposium kibbe 201704
 
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services MarketplaceHow Researchers Can Get Science Done Faster Using an R&D Services Marketplace
How Researchers Can Get Science Done Faster Using an R&D Services Marketplace
 
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
Dr. Kathleen H. Hartman - Commercial Aquaculture Health Program Standards (CA...
 

Viewers also liked

Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
National Ovarian Cancer Coalition
 
Newly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MDNewly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MD
Ovarian Cancer Research Fund Alliance
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddah
Basalama Ali
 
Prophylactic Salpingectomy
Prophylactic SalpingectomyProphylactic Salpingectomy
Prophylactic Salpingectomy
Sujoy Dasgupta
 
Ovaries
OvariesOvaries
Ovaries
Prasad CSBR
 
Ovarian Cancer
Ovarian CancerOvarian Cancer

Viewers also liked (6)

Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
Immunotherapy and Recurrent Ovarian Cancer: Time for New Paradigms!
 
Newly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MDNewly Diagnosed, Stephanie Wethington, MD
Newly Diagnosed, Stephanie Wethington, MD
 
Ov ca prevention jeddah
Ov ca prevention jeddahOv ca prevention jeddah
Ov ca prevention jeddah
 
Prophylactic Salpingectomy
Prophylactic SalpingectomyProphylactic Salpingectomy
Prophylactic Salpingectomy
 
Ovaries
OvariesOvaries
Ovaries
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 

Similar to Your Advocacy at Work: The DoD Academy, Karen Wylie, PhD

CCDI Overview November 2022
CCDI Overview November 2022CCDI Overview November 2022
CCDI Overview November 2022
Warren Kibbe
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
Fight Colorectal Cancer
 
Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)
Marianne Dailey
 
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
World Cancer Research Fund International
 
Colorado Clinical & Translational Science Award
Colorado Clinical & Translational Science AwardColorado Clinical & Translational Science Award
Colorado Clinical & Translational Science Award
guest041fdb
 
Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
 Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
aryan532920
 
Critical Pathways to Improved Care for Serious Illness
Critical Pathways to Improved Care for Serious IllnessCritical Pathways to Improved Care for Serious Illness
Critical Pathways to Improved Care for Serious Illness
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps Conference Services and CME
 
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
Colon Cancer Challenge Foundation
 
Corporate Presentation: August 2016
Corporate Presentation: August 2016Corporate Presentation: August 2016
Corporate Presentation: August 2016
Exact Sciences
 
Exact Sciences Corporate Presentation: August 2016
Exact Sciences Corporate Presentation: August 2016Exact Sciences Corporate Presentation: August 2016
Exact Sciences Corporate Presentation: August 2016
Exact Sciences
 
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
Canadian Cancer Survivor Network
 
September 2016-corporate-presentation-final
September 2016-corporate-presentation-finalSeptember 2016-corporate-presentation-final
September 2016-corporate-presentation-final
Exact Sciences
 
Coleman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative SymposiumColeman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative Symposium
Jennifer Amdur Spitz
 
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare ConferenceExact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences
 
Oncology Treatment Guidelines : The Rules and Rationale
Oncology  Treatment Guidelines :The Rules and RationaleOncology  Treatment Guidelines :The Rules and Rationale
Oncology Treatment Guidelines : The Rules and Rationale
Pharmacy @ Institut Kanser Negara
 
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
Ryan Kerr
 
3Capstone Section 1Christina ValvoHA499.docx
3Capstone Section 1Christina ValvoHA499.docx3Capstone Section 1Christina ValvoHA499.docx
3Capstone Section 1Christina ValvoHA499.docx
tamicawaysmith
 
Andrea Dwyyer Call-on Congress panel speaker
Andrea Dwyyer  Call-on Congress panel speakerAndrea Dwyyer  Call-on Congress panel speaker
Andrea Dwyyer Call-on Congress panel speaker
Fight Colorectal Cancer
 
Gastric-Effective-Practices-in-Gastric-Cancer-Programs
Gastric-Effective-Practices-in-Gastric-Cancer-ProgramsGastric-Effective-Practices-in-Gastric-Cancer-Programs
Gastric-Effective-Practices-in-Gastric-Cancer-Programs
Brissan Guardado
 

Similar to Your Advocacy at Work: The DoD Academy, Karen Wylie, PhD (20)

CCDI Overview November 2022
CCDI Overview November 2022CCDI Overview November 2022
CCDI Overview November 2022
 
Early Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working MeetingEarly Age Onset (EAO) Working Meeting
Early Age Onset (EAO) Working Meeting
 
Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)Molecular Testing Supplement (Final)
Molecular Testing Supplement (Final)
 
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
Continuous Update Project Overview (Conference: Diet and cancer: from prevent...
 
Colorado Clinical & Translational Science Award
Colorado Clinical & Translational Science AwardColorado Clinical & Translational Science Award
Colorado Clinical & Translational Science Award
 
Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
 Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx
 
Critical Pathways to Improved Care for Serious Illness
Critical Pathways to Improved Care for Serious IllnessCritical Pathways to Improved Care for Serious Illness
Critical Pathways to Improved Care for Serious Illness
 
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
 
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
4th Annual Early Age Onset Colorectal Cancer Summit: Transforming Family Heal...
 
Corporate Presentation: August 2016
Corporate Presentation: August 2016Corporate Presentation: August 2016
Corporate Presentation: August 2016
 
Exact Sciences Corporate Presentation: August 2016
Exact Sciences Corporate Presentation: August 2016Exact Sciences Corporate Presentation: August 2016
Exact Sciences Corporate Presentation: August 2016
 
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
CanREValue: A Framework for the Incorporation of Real-World Evidence (RWE) in...
 
September 2016-corporate-presentation-final
September 2016-corporate-presentation-finalSeptember 2016-corporate-presentation-final
September 2016-corporate-presentation-final
 
Coleman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative SymposiumColeman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative Symposium
 
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare ConferenceExact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare Conference
 
Oncology Treatment Guidelines : The Rules and Rationale
Oncology  Treatment Guidelines :The Rules and RationaleOncology  Treatment Guidelines :The Rules and Rationale
Oncology Treatment Guidelines : The Rules and Rationale
 
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
ROI of Colorectal Cancer Screening - Colorado Cancer Coalition - Colorado Bus...
 
3Capstone Section 1Christina ValvoHA499.docx
3Capstone Section 1Christina ValvoHA499.docx3Capstone Section 1Christina ValvoHA499.docx
3Capstone Section 1Christina ValvoHA499.docx
 
Andrea Dwyyer Call-on Congress panel speaker
Andrea Dwyyer  Call-on Congress panel speakerAndrea Dwyyer  Call-on Congress panel speaker
Andrea Dwyyer Call-on Congress panel speaker
 
Gastric-Effective-Practices-in-Gastric-Cancer-Programs
Gastric-Effective-Practices-in-Gastric-Cancer-ProgramsGastric-Effective-Practices-in-Gastric-Cancer-Programs
Gastric-Effective-Practices-in-Gastric-Cancer-Programs
 

More from Ovarian Cancer Research Fund Alliance

Sex and Cancer, Jeanne Carter, PhD
Sex and Cancer, Jeanne Carter, PhDSex and Cancer, Jeanne Carter, PhD
Sex and Cancer, Jeanne Carter, PhD
Ovarian Cancer Research Fund Alliance
 
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MD
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MDGenetics: Beyond BRCA, Reem Saadeh-Haddad, MD
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MD
Ovarian Cancer Research Fund Alliance
 
Genetics: Beyond BRCA, Ursula Matulonis, MD
Genetics: Beyond BRCA, Ursula Matulonis, MDGenetics: Beyond BRCA, Ursula Matulonis, MD
Genetics: Beyond BRCA, Ursula Matulonis, MD
Ovarian Cancer Research Fund Alliance
 
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
Ovarian Cancer Research Fund Alliance
 
Expert Roundtable, Michael Seiden, MD, PhD
Expert Roundtable, Michael Seiden, MD, PhDExpert Roundtable, Michael Seiden, MD, PhD
Expert Roundtable, Michael Seiden, MD, PhD
Ovarian Cancer Research Fund Alliance
 
When Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MDWhen Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MD
Ovarian Cancer Research Fund Alliance
 
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
Ovarian Cancer Research Fund Alliance
 
Cancer in the Workplace, Ann Hodges
Cancer in the Workplace, Ann HodgesCancer in the Workplace, Ann Hodges
Cancer in the Workplace, Ann Hodges
Ovarian Cancer Research Fund Alliance
 
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhDYour Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
Ovarian Cancer Research Fund Alliance
 
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhDYour Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
Ovarian Cancer Research Fund Alliance
 
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Ovarian Cancer Research Fund Alliance
 
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MDOvarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research Fund Alliance
 
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
Ovarian Cancer Research Fund Alliance
 
In the Know About Recurrence, Sarah Adams, MD
In the Know About Recurrence, Sarah Adams, MDIn the Know About Recurrence, Sarah Adams, MD
In the Know About Recurrence, Sarah Adams, MD
Ovarian Cancer Research Fund Alliance
 
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhDNewly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
Ovarian Cancer Research Fund Alliance
 
Partner Member Breakout Colleen Legge
Partner Member Breakout  Colleen LeggePartner Member Breakout  Colleen Legge
Partner Member Breakout Colleen Legge
Ovarian Cancer Research Fund Alliance
 
Genetics 101: Sandra Brown, MS, LCGC
Genetics 101: Sandra Brown, MS, LCGCGenetics 101: Sandra Brown, MS, LCGC
Genetics 101: Sandra Brown, MS, LCGC
Ovarian Cancer Research Fund Alliance
 
Discover Personalized Medicine: Gordon Mills, PD, PhD
Discover Personalized Medicine: Gordon Mills, PD, PhDDiscover Personalized Medicine: Gordon Mills, PD, PhD
Discover Personalized Medicine: Gordon Mills, PD, PhD
Ovarian Cancer Research Fund Alliance
 
Discover Personalized Medicine: Oliver Dorigo, MD, PhD
Discover Personalized Medicine: Oliver Dorigo, MD, PhDDiscover Personalized Medicine: Oliver Dorigo, MD, PhD
Discover Personalized Medicine: Oliver Dorigo, MD, PhD
Ovarian Cancer Research Fund Alliance
 
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
Ovarian Cancer Research Fund Alliance
 

More from Ovarian Cancer Research Fund Alliance (20)

Sex and Cancer, Jeanne Carter, PhD
Sex and Cancer, Jeanne Carter, PhDSex and Cancer, Jeanne Carter, PhD
Sex and Cancer, Jeanne Carter, PhD
 
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MD
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MDGenetics: Beyond BRCA, Reem Saadeh-Haddad, MD
Genetics: Beyond BRCA, Reem Saadeh-Haddad, MD
 
Genetics: Beyond BRCA, Ursula Matulonis, MD
Genetics: Beyond BRCA, Ursula Matulonis, MDGenetics: Beyond BRCA, Ursula Matulonis, MD
Genetics: Beyond BRCA, Ursula Matulonis, MD
 
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
Growing up with Ovarian Cancer: Facing the Battle as a Young Adult, Julie Lar...
 
Expert Roundtable, Michael Seiden, MD, PhD
Expert Roundtable, Michael Seiden, MD, PhDExpert Roundtable, Michael Seiden, MD, PhD
Expert Roundtable, Michael Seiden, MD, PhD
 
When Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MDWhen Cancer Comes Back, Sarah Adams, MD
When Cancer Comes Back, Sarah Adams, MD
 
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
Mello Abrams Lecture: Research in Ovarian Cancer, Where Are We Now?, Michael ...
 
Cancer in the Workplace, Ann Hodges
Cancer in the Workplace, Ann HodgesCancer in the Workplace, Ann Hodges
Cancer in the Workplace, Ann Hodges
 
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhDYour Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
Your Advocacy at Work: The DoD Academy, Elizabeth Poole, PhD
 
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhDYour Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
Your Advocacy at Work: The DoD Academy, Karen McLean, MD, PhD
 
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
 
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MDOvarian Cancer Research and Prevention, Andrew Berchuck, MD
Ovarian Cancer Research and Prevention, Andrew Berchuck, MD
 
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
Annie Ellis Patient Perspective from Ovarian Cancer Endpoints Workshop hosted...
 
In the Know About Recurrence, Sarah Adams, MD
In the Know About Recurrence, Sarah Adams, MDIn the Know About Recurrence, Sarah Adams, MD
In the Know About Recurrence, Sarah Adams, MD
 
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhDNewly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
Newly Diagnosed: Ovarian Cancer 101, Gordon Mills, MD, PhD
 
Partner Member Breakout Colleen Legge
Partner Member Breakout  Colleen LeggePartner Member Breakout  Colleen Legge
Partner Member Breakout Colleen Legge
 
Genetics 101: Sandra Brown, MS, LCGC
Genetics 101: Sandra Brown, MS, LCGCGenetics 101: Sandra Brown, MS, LCGC
Genetics 101: Sandra Brown, MS, LCGC
 
Discover Personalized Medicine: Gordon Mills, PD, PhD
Discover Personalized Medicine: Gordon Mills, PD, PhDDiscover Personalized Medicine: Gordon Mills, PD, PhD
Discover Personalized Medicine: Gordon Mills, PD, PhD
 
Discover Personalized Medicine: Oliver Dorigo, MD, PhD
Discover Personalized Medicine: Oliver Dorigo, MD, PhDDiscover Personalized Medicine: Oliver Dorigo, MD, PhD
Discover Personalized Medicine: Oliver Dorigo, MD, PhD
 
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
Breakout: Growing Up with Ovarian Cancer: facing the Battle as a Young Adult:...
 

Recently uploaded

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 

Recently uploaded (20)

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 

Your Advocacy at Work: The DoD Academy, Karen Wylie, PhD

  • 1. Overview of the DoD Ovarian Cancer Research Program Karen Wylie, Ph.D. DoD OCRP Science Officer The Geneva Foundation, In support of the Congressionally Directed Medical Research Programs The views expressed in this presentation are those of the author and may not reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government.
  • 2. 2 Outline  Overview of DoD OCRP & CDMRP  DoD OCRP consumers  Impact of the DoD OCRP  Consortium Award  Outcomes Consortium Award  Ovarian Cancer Academy
  • 3. 3 History of the CDMRP and DoD OCRP Congressionally Directed Medical Research Programs (CDMRP) Organization which funds biomedical research globally Unique partnership: U.S. Congress, Public & U.S. Military  1992 grassroots campaign to increase Breast Cancer research funding  Congress responded, DoD directed to manage $210 M  CDMRP established, Breast Cancer Research Program 1st program In 1997, the Ovarian Cancer Research Program (OCRP) was added to CDMRP with an initial appropriation of $7.5 M. FY1992 – FY2015 CDMRP has  Grown to include 27 research programs  Cancer, neurologic, orthopedic and military relevant areas  Managed ~$9.7 Billion in appropriations
  • 4. 4 How does the OCRP fit into the DoD? ARMY MEDICAL COMMAND (MEDCOM) DEPARTMENT OF DEFENSE DEPARTMENT OF THE ARMY MEDICAL RESEARCH AND MATERIEL COMMAND (USAMRMC) CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS OCRP OVARIAN CANCER RESEARCH PROGRAM
  • 5. 5 DoD OCRP Vision and Mission Vision: Eliminate ovarian cancer. Mission: To support patient-centered research to prevent, detect, treat & cure ovarian cancer. FY1997–FY2015 DoD OCRP managed appropriations of $256.5 M DoD OCRP addresses critical issues for the OC patient & research communities through different funding opportunities.
  • 6. 6 Outline  Overview of DoD OCRP & CDMRP  DoD OCRP consumers  Impact of the DoD OCRP  Consortium Award  Outcomes Consortium Award  Ovarian Cancer Academy
  • 7. 7 DoD OCRP Consumers: Role and Numbers Who is an OCRP consumer? An OCRP consumer is a patient or a survivor living with ovarian cancer. OCRP Consumer contributions  Peer Review: 94, who provided reviews for 225 panel assignments  Programmatic Review: 9 Standing reviewers 10 Ad-hoc reviewers
  • 8. 8 Unique Partnerships Demonstrate need Participate at all levels Passion and perspective Innovation and gaps Risk/Benefit Product- oriented Add funds to budget Targeted guidance Program management Contracting actions Regulatory requirements IMPROVE HEALTH OUTCOME
  • 9. 9 DoD OCRP Funding 0 5 10 15 20 25 FY97 FY98 FY99 FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 Millions($) Fiscal Year Congressional Appropriations for DoD OCRP FY97-FY16
  • 10. 10 Outline  Overview of DoD OCRP & CDMRP  OCRP consumers  Impact of the DoD OCRP  Consortium Award  Outcomes Consortium Award  Ovarian Cancer Academy
  • 11. 11 Impact of the DoD OCRP Unmet Needs / Long-Term Research Priorities  Understand initiation and progression of OC  Develop / improve diagnosis and treatment  Increase prevention, improve QOL for survivors  Investigate tumor response / resistance to treatment  Develop and validate research tools to study OC  Recruit / retain exceptional OC researchers
  • 12. 12 DoD OCRP Consortium Award Focus … Prevention Intent To support a major multi-institutional research effort  Focus on identifying and characterizing early changes in OC  Innovative studies to reduce burden of OC through prevention. FY10 Consortium Award: Dr. Kurman’s group / JHU “Prevention of Ovarian High-Grade Serous Carcinoma by Elucidating Its Early Changes”  4 preclinical & 1 epidemiology project; JHU, MSKCC, Yale & UHN Toronto  Hypothesis: Precursor of many HGSCs begins in the fallopian tube  Results: Evaluated STICS as precursor lesions of HGSCs Identifying molecular changes that precede the development of STICs  Website: http://www.ovariancancerprevention.org/
  • 13. 13 Outcomes Consortium Award Focus … Increase Survivorship Intent  Identify & understand predictors of disease outcomes  Shift balance: Short-Term Survivors to Long-Term Survivors  FY15 Outcomes Consortium Award  Impact: accelerate predictors of disease outcomes into patient care.  Consumer advocates involved in significant aspects of the proposed project such as design, recruitment, and evaluation  Two 4-year awards made by September 2016
  • 14. 14 Outcomes Consortium Award Focus … Increase Survivorship  Dr. Birrer’s group (Massachusetts General Hospital)  “The Genomic, Epigenomic, & Quality-of-Life Characteristics of Long-Term Survivors of OC”  Characterize genomic, biologic, and biobehavioral basis for long-term survivors of epithelial OC  Dr. Pike’s group (Memorial Sloan Kettering Cancer Ctr.)  “Multidisciplinary Ovarian Cancer Outcomes Group (MOCOG)”  Investigate genetic, genomic, immune, & epidemiological factors that may contribute, singly or in combination, to long- term survival
  • 15. Ovarian Cancer Academy: The Need “Reducing the burden of ovarian cancer requires recruiting and, more importantly, mentoring a group of scientists and clinicians who are committed to building sustained and productive careers in ovarian cancer research.” Dr. Michael Seiden, Integration Panel Chair, FY09 Building a Critical Mass of Dedicated OC Researchers
  • 16. 16 Ovarian Cancer Academy: Challenges Challenges in Producing Dedicated OCRP Researchers  Limited number of medical or research centers with critical mass of mentors dedicated to OC research  Funding an institutional training grant at a single institution is expensive and often ineffective  Too few junior scientists and physicians heading into OC as a research career choice  Peer groups for junior faculty interested in OC often limited within their institutions
  • 17. 17 Ovarian Cancer Academy: Breaking Barriers Focus…Seeding Next Generation of Dedicated OC Researchers  Interactive Academy in a Virtual Environment  Consists of:  Academy Dean and Assistant Dean  ~14 Early-Career Investigator (ECI)-Designated Mentor pairs from different institutions  Provides  Mentoring  Networking  Peer group  Collaborative opportunities
  • 18. 18 Ovarian Cancer Academy (OCA) OCA: Early-Career Investigators, their Mentors and Leadership
  • 19. 19 Search Awards Site http://cdmrp.army.mil Research Highlights/News » 19 Search Awards & PublicationsResearch Programs
  • 20. 2020 Thank you… For Your Unwavering Support